SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PRCS
An SI Board Since February 2000
Posts SubjectMarks Bans
78 13 0
Emcee:  Witold Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
28Monday May 28, 3:28 pm Eastern Time Drug Company to Pay $840M for Scam Drug CompMiljenko Zuanic-5/28/2001
27thestreet.com Reference to Abarelix at bottom of article under Amgen heading.Harold Engstrom-5/8/2001
26Interesting that Amgen guides to end of year... do you think that PRCS and AmgenHarold Engstrom-4/27/2001
25This morning's PR from PRCS includes this: As previously announced, we expelrb-4/27/2001
24Amgen reportedly indicated Abarelix approval by year end. marketwatch.com The Harold Engstrom-4/27/2001
23Tuck, Abarelix Depot has the potential to be a blockbuster, but it may fall shorMark Bong-4/8/2001
22Now the owner of some PRCS shares. Sold puts, and they got exercised before I rtuck-4/8/2001
21Yes, I grabbed some additional shares at $15. I feel that the very fast comebackMark Bong-3/26/2001
20Did anybody load up on PRCS after the drop into the low teens abyss? I sold my pSpekulatius-3/25/2001
19The priority review for Abarelix is certainly good news. First, this means that Spekulatius-1/28/2001
18FDA Approves Priority Review for Abarelix Depot NDA for Prostate Cancer CAMBRIDMark Bong-1/25/2001
17AMGN and PRCS seem to be taking the line that Abarelix has a better therapeutic Mark Bong-1/21/2001
16Medscape - Abarelix This is an interesting article about hormone treatment of prSpekulatius-1/21/2001
15PRCS JPMorganChaseHQ Healthcare Conference Presentation Tuck, this is from noteMark Bong-1/11/2001
14CEO interview: bigcharts.comJEB-1/11/2001
13Anything new or earth-shattering in here? biz.yahoo.com Doesn't look it totuck-1/11/2001
12Biotech Insight News Alert: <b>Praecis</b>, Imclone, Celgene, Cell TJim Oravetz-1/9/2001
11A bit old, but I'm behind on my reading. Emphasis mine. Jason <i> Mtnsaf-1/3/2001
10I agree. I remain interested in seeing more information on their collaboration wMark Bong-12/14/2000
9The NDA application is certainly a milestone for PRCS. I am impressed by the busSpekulatius-12/14/2000
8PRAECIS PHARMACEUTICALS Submits NDA It is nice that the company is able to meetMark Bong-12/13/2000
7PRCS article: streetsideinvestor.comJEB-9/22/2000
6WSJ discussion of AMGN and PRCS Drug Candidates This WSJ article sounds like reMark Bong-9/15/2000
5So far so good! eomWitold-9/3/2000
4The money flow into PRCS is quite good. No wonder the stock has been on a tear. Mark Bong-8/10/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News